sefulness of visceral fat measuring device HDS-2000 in obesity and metabolic syndrome
Not Applicable
- Conditions
- 1. healthy subjects, normal weight obesity, 2. obesity, 3. metabolic syndrome and pre-metabolic syndrome.
- Registration Number
- JPRN-UMIN000009558
- Lead Sponsor
- Clinical Research Institute, Narional Hospital Organization, Kyoto Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
1. Servere Liver Dysfunction and Liver cirrhosis, 2. Severe Renal Dysfunction
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Body weight, BMI, waist circumference, abdominal fat area.
- Secondary Outcome Measures
Name Time Method blood pressure, pulse, blood tests (HbA1c, FPG, IRI, CPR, TG, LDL-C, HDL-C), adipocytokines (leptin, adiponectin), oxidation and markers (SAA-LDL, hs-CRP, IL-6, IL-10), and atherosclerotic index (PWV / CAVI)